866-274-4009 Contact Us

New Talk: Make Your Supply Chain Fit for Purpose to Enable a Seamless Delivery Process

September 22, 2022

Panel at Reuters Cell & Gene Therapy USA 2022

Joerg Ahlgrimm, CEO of CBM participated in a recent panel with industry leading experts, discussing how to optimize vein-to-vein supply chains to seamlessly deliver critical cell therapies to patients.

The discussion covered:

• Analyzing the difference between building in house units vs partnering with CMOs and understand their relative benefits to craft a business model that suits you

• Avoiding launch failure by tailoring a bespoke delivery network to ensure optimum product quality and patient satisfaction

• Examining the differences in autologous vs allogeneic therapy production to enhance your own pipeline for maximum efficiency

View the full video here:

Contact Us Now